Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 4:00 pm Unchanged | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | TANG CAPITAL PARTNERS LP | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 3:56 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | ARMISTICE CAPITAL LLC | 3,770,000 6.71% | 3,770,000 (New Position) | View |
| 2024-02-14 1:55 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Alyeska Investment Group L.P. | 5,855,597 9.99% | 5,855,597 (New Position) | View |
| 2024-01-11 4:53 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | Empery Asset Management LP | 55,675,674 9.99% | 55,675,674 (New Position) | View |
| 2024-01-03 4:23 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | SABBY MANAGEMENT LLC | 5,205,348 11% | 5,205,348 (New Position) | View |
| 2023-02-14 4:00 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | TANG CAPITAL PARTNERS LP | 4,500,419 7.4% | 219,503 (+5.13%) | View |
| 2022-12-27 5:05 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | TANG CAPITAL PARTNERS LP | 4,280,916 7.4% | 4,280,916 (New Position) | View |
| 2022-07-08 4:52 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | BlackRock Inc. BLK | 341,736 1.1% | 341,736 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | BlackRock Inc. BLK | 30,631,558 6.2% | 30,631,558 (New Position) | View |
| 2021-02-16 5:09 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | ARMISTICE CAPITAL LLC | 0 0% | -598,399 (Position Closed) | View |
| 2021-02-16 10:09 am Sale | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | CVI Investments Inc. | 111,250 0.1% | -1,131,265 (-91.05%) | View |
| 2021-02-11 5:15 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | Altium Capital Management LP | 0 0% | -1,546,082 (Position Closed) | View |
| 2021-02-10 8:20 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | RENAISSANCE TECHNOLOGIES LLC | 271,164 0.14% | -49,061 (-15.32%) | View |
| 2021-01-04 6:42 pm Sale | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | SABBY MANAGEMENT LLC | 100,000 11% | -1,135,771 (-91.91%) | View |
| 2020-02-14 3:39 pm Unchanged | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | Altium Capital Management LP | 1,546,082 9.9% | 0 (Unchanged) | View |
| 2020-02-14 3:09 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | ARMISTICE CAPITAL LLC | 598,399 9.99% | 598,399 (New Position) | View |
| 2020-02-14 10:22 am Sale | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | Iroquois Capital Management LLC | 100,000 2.4% | -900,000 (-90.00%) | View |
| 2020-02-14 09:03 am Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | CVI Investments Inc. | 1,242,515 9.9% | 1,131,265 (+1016.87%) | View |
| 2020-02-12 2:33 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | RENAISSANCE TECHNOLOGIES LLC | 320,225 7.96% | 320,225 (New Position) | View |
| 2020-02-10 3:15 pm Purchase | 13G | TONIX PHARMACEUTICALS HLDG COR TNXP | CVI Investments Inc. | 111,250 2.7% | 111,250 (New Position) | View |